文献速递老年综合评估老年慢病共病管理

老年癌症患者多病共存评估中CIRS-G量表的可靠性:ELCAPA队列结果

Reliability of the cumulative illness rating scale for geriatrics for assessing multimorbidity in older patients with cancer: results from the ELCAPA cohort.
PubMed 文献 · Age Ageing · 2026-01-01

该研究基于ELCAPA前瞻性队列,评估老年综合疾病评定量表(CIRS-G)在70岁及以上癌症患者中的可靠性。分层随机抽取150例评估评分者间信度,随机抽取30例由两名研究者评估评分者内信度。结果显示评分者间ICC为0.53,明显低于文献值;评分者内ICC分别为0.66和0.77。提示在真实肿瘤临床环境中一致应用CIRS-G可能具有挑战性。

要点

  • CIRS-G在老年癌症患者中评分者间信度ICC为0.53,低于文献报告水平。
  • 两名研究者的评分者内信度ICC分别为0.66和0.77。
  • 研究提示需修订评分指南以改善CIRS-G在老年癌症患者中的可靠性。

核心结论

  • 在70岁及以上癌症患者中,CIRS-G评分者间信度明显低于既往文献值,一致应用可能具有挑战性。

研究设计与样本

  • 基于ELCAPA前瞻性队列,纳入70岁及以上癌症患者,分层随机抽取150例评估评分者间信度,随机抽取30例由两名研究者评估评分者内信度。

主要发现

  • 评分者间信度ICC为0.53(95%CI 0.12-0.74),明显低于文献值。
  • 研究者1的评分者内信度ICC为0.66(95%CI 0.40-0.82)。
  • 研究者2的评分者内信度ICC为0.77(95%CI 0.54-0.89)。

临床怎么用

  • 在老年癌症患者中应用CIRS-G评估多病共存时,需注意评分者间一致性可能有限。
  • 建议通过修订评分指南来改善CIRS-G在真实肿瘤临床环境中的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Comorbidities are common in older patients with cancer. The Cumulative Illness Rating Scale for Geriatrics (CIRS-G, developed in 1992) provides a comprehensive assessment of comorbidities and is independently associated with the mortality rate, the hospital admission rate and functional limitations. Although the literature data indicate that the CIRS-G's reliability is good to very good, most of the studies were small and did not include cancer patients. Here, we evaluated the CIRS-G's reliability in a large, prospective cohort of cancer patients aged 70 or over. A stratified, random sample of 150 patients was used to assess inter-rater reliability, and a random sample of 30 patients was evaluated by two investigators to assess intra-rater reliability. For inter-rater reliability, the observed intraclass correlation coefficient (ICC) [95% confidence interval] of 0.53 [0.12-0.74] was substantially lower than the literature values. For intra-rater reliability, the ICC was 0.66 [0.40-0.82] for investigator 1 and 0.77 [0.54-0.89) for investigator 2. These findings suggest that applying the CIRS-G consistently across raters and centres may be challenging in real-world oncology settings for older patients with cancer. Revising the scoring guidelines could help improve its reliability.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Benderra MA, Caillet P, Aregui A, et al. Reliability of the cumulative illness rating scale for geriatrics for assessing multimorbidity in older patients with cancer: results from the ELCAPA cohort. Age Ageing. 2026. PMID: 41482954. doi:10.1093/ageing/afaf369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。